Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138181000087112 | NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 22031000087117 | Men-C-C NeisVac-C GSK | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 22051000087114 | NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 76311000087113 | Men-C-C NeisVac-C GSK | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of Neisseria meningitidis serogroup C capsular polysaccharide conjugated to tetanus toxoid protein (substance) | true | Inferred relationship | Some | 1 | |
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Count of active ingredient | un | false | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product) | true | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Meningococcal C conjugate vaccine (product) | false | Inferred relationship | Some | ||
| NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Meningococcus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR